365 related articles for article (PubMed ID: 25675199)
1. Homoarginine and Clinical Outcomes in Renal Transplant Recipients: Results From the Assessment of Lescol in Renal Transplantation Study.
Drechsler C; Pihlstrøm H; Meinitzer A; Pilz S; Tomaschitz A; Abedini S; Fellstrom B; Jardine AG; Wanner C; März W; Holdaas H
Transplantation; 2015 Jul; 99(7):1470-6. PubMed ID: 25675199
[TBL] [Abstract][Full Text] [Related]
2. Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study.
Svensson M; Dahle DO; Mjøen G; Weihrauch G; Scharnagl H; Dobnig H; März W; Jardine A; Fellström B; Holdaas H
Nephrol Dial Transplant; 2012 Jun; 27(6):2571-5. PubMed ID: 22172725
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular risk and renal transplantation: post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) Study.
Jardine AG; Fellström B; Logan JO; Cole E; Nyberg G; Grönhagen-Riska C; Madsen S; Neumayer HH; Maes B; Ambühl P; Olsson AG; Pedersen T; Holdaas H
Am J Kidney Dis; 2005 Sep; 46(3):529-36. PubMed ID: 16129216
[TBL] [Abstract][Full Text] [Related]
4. Symmetric dimethylarginine as predictor of graft loss and all-cause mortality in renal transplant recipients.
Pihlstrøm H; Mjøen G; Dahle DO; Pilz S; Midtvedt K; März W; Abedini S; Holme I; Fellström B; Jardine A; Holdaas H
Transplantation; 2014 Dec; 98(11):1219-25. PubMed ID: 24999963
[TBL] [Abstract][Full Text] [Related]
5. Time-varying maximal proteinuria correlates with adverse cardiovascular events and graft failure in kidney transplant recipients.
Jeon HJ; Kim CT; An JN; Lee H; Kim H; Park SK; Joo KW; Lim CS; Jung IM; Ahn C; Kim YS; Kim YH; Lee JP
Nephrology (Carlton); 2015 Dec; 20(12):945-51. PubMed ID: 26040625
[TBL] [Abstract][Full Text] [Related]
6. No detrimental effect on renal function during long-term use of fluvastatin in renal transplant recipients in the Assessment of Lescol in Renal Transplantation (ALERT) study.
Fellström B; Abedini S; Holdaas H; Jardine AG; Staffler B; Gimpelewicz C;
Clin Transplant; 2006; 20(6):732-9. PubMed ID: 17100723
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism.
Pihlstrøm H; Dahle DO; Mjøen G; Pilz S; März W; Abedini S; Holme I; Fellström B; Jardine AG; Holdaas H
Transplantation; 2015 Feb; 99(2):351-9. PubMed ID: 25594550
[TBL] [Abstract][Full Text] [Related]
8. High plasma guanidinoacetate-to-homoarginine ratio is associated with high all-cause and cardiovascular mortality rate in adult renal transplant recipients.
Hanff E; Said MY; Kayacelebi AA; Post A; Minovic I; van den Berg E; de Borst MH; van Goor H; Bakker SJL; Tsikas D
Amino Acids; 2019 Nov; 51(10-12):1485-1499. PubMed ID: 31535220
[TBL] [Abstract][Full Text] [Related]
9. Inflammation-associated graft loss in renal transplant recipients.
Dahle DO; Mjøen G; Oqvist B; Scharnagl H; Weihrauch G; Grammer T; März W; Abedini S; Norby GE; Holme I; Fellström B; Jardine A; Holdaas H
Nephrol Dial Transplant; 2011 Nov; 26(11):3756-61. PubMed ID: 21511816
[TBL] [Abstract][Full Text] [Related]
10. Renal dysfunction as a risk factor for mortality and cardiovascular disease in renal transplantation: experience from the Assessment of Lescol in Renal Transplantation trial.
Fellström B; Jardine AG; Soveri I; Cole E; Grönhagen-Riska C; Neumayer HH; Maes B; Gimpelewicz C; Holdaas H;
Transplantation; 2005 May; 79(9):1160-3. PubMed ID: 15880062
[TBL] [Abstract][Full Text] [Related]
11. Post-Transplant Hypophosphatemia and the Risk of Death-Censored Graft Failure and Mortality after Kidney Transplantation.
van Londen M; Aarts BM; Deetman PE; van der Weijden J; Eisenga MF; Navis G; Bakker SJL; de Borst MH;
Clin J Am Soc Nephrol; 2017 Aug; 12(8):1301-1310. PubMed ID: 28546442
[TBL] [Abstract][Full Text] [Related]
12. Graft loss risk in renal transplant recipients with metabolic syndrome: subgroup analyses of the ALERT trial.
Soveri I; Abedini S; Holdaas H; Jardine A; Eriksson N; Fellström B
J Nephrol; 2012; 25(2):245-54. PubMed ID: 21725919
[TBL] [Abstract][Full Text] [Related]
13. Donor-recipient age difference and graft survival in living donor kidney transplantation.
Lee YJ; Chang JH; Choi HN; Jung JY; Kim YS; Chung WK; Park YH; Lee HH
Transplant Proc; 2012 Jan; 44(1):270-2. PubMed ID: 22310630
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone and clinical outcome in kidney transplant patients with optimal transplant function.
Bleskestad IH; Bergrem H; Leivestad T; Hartmann A; Gøransson LG
Clin Transplant; 2014 Apr; 28(4):479-86. PubMed ID: 25649861
[TBL] [Abstract][Full Text] [Related]
15. Urinary creatinine excretion reflecting muscle mass is a predictor of mortality and graft loss in renal transplant recipients.
Oterdoom LH; van Ree RM; de Vries AP; Gansevoort RT; Schouten JP; van Son WJ; Homan van der Heide JJ; Navis G; de Jong PE; Gans RO; Bakker SJ
Transplantation; 2008 Aug; 86(3):391-8. PubMed ID: 18698241
[TBL] [Abstract][Full Text] [Related]
16. Effects of fluvastatin on cardiac events in renal transplant patients: ALERT (Assessment of Lescol in Renal Transplantation) study design and baseline data.
Holdaas H; Fellström B; Holme I; Nyberg G; Fauchald P; Jardine A; Grönhagen-Riska C; Madsen S; Neumayer HH; Cole E; Maes B; Weinreich T; Olsson AG; Pedersen TR; Benghozi R; Hartmann A;
J Cardiovasc Risk; 2001 Apr; 8(2):63-71. PubMed ID: 11324372
[TBL] [Abstract][Full Text] [Related]
17. Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial.
Fellström B; Holdaas H; Jardine AG; Holme I; Nyberg G; Fauchald P; Grönhagen-Riska C; Madsen S; Neumayer HH; Cole E; Maes B; Ambühl P; Olsson AG; Hartmann A; Logan JO; Pedersen TR;
Kidney Int; 2004 Oct; 66(4):1549-55. PubMed ID: 15458450
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for reaching renal endpoints in the assessment of Lescol in renal transplantation (ALERT) trial.
Fellström B; Holdaas H; Jardine AG; Nyberg G; Grönhagen-Riska C; Madsen S; Neumayer HH; Cole E; Maes B; Ambühl P; Olsson AG; Staffler B; Pedersen TR;
Transplantation; 2005 Jan; 79(2):205-12. PubMed ID: 15665769
[TBL] [Abstract][Full Text] [Related]
19. Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial.
Holdaas H; Fellström B; Jardine AG; Holme I; Nyberg G; Fauchald P; Grönhagen-Riska C; Madsen S; Neumayer HH; Cole E; Maes B; Ambühl P; Olsson AG; Hartmann A; Solbu DO; Pedersen TR;
Lancet; 2003 Jun; 361(9374):2024-31. PubMed ID: 12814712
[TBL] [Abstract][Full Text] [Related]
20. High urinary homoarginine excretion is associated with low rates of all-cause mortality and graft failure in renal transplant recipients.
Frenay AR; Kayacelebi AA; Beckmann B; Soedamah-Muhtu SS; de Borst MH; van den Berg E; van Goor H; Bakker SJ; Tsikas D
Amino Acids; 2015 Sep; 47(9):1827-36. PubMed ID: 26142633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
